CONNECT Trial Demonstrates Clinical and Economic Benefits of Remote Monitoring in Reducing Hospital Stays and In-Office Visits for Cardiac Patients Treated with Implantable Devices MINNEAPOLIS – ...
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE:MDT) today announced the start of its CONNECT SM trial, which will further substantiate the impact of Medtronic’s most advanced devices with Conexus™ ...
Medtronic, Inc. has obtained CE Mark approval and is launching the automatic version of the Medtronic CareLink Network with Conexus Wireless Telemetry in the European Union.The Medtronic CareLink ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care shifts care ...
Minneapolis, MN - Medtronic Inc's CareLink? programmer, whose Remote View software allows remote consulting via PC or laptop computer, has received FDA approval and the CE Mark. Medtronic is beginning ...
Medtronic Inc. (NYSE: MDT) and St. Jude Inc. (NYSE: STJ) have released similar wireless transmission devices that are designed to send data from patients’ implanted cardiac devices to physicians. It’s ...
CONNECT Trial Demonstrates Clinical and Economic Benefits of Remote Monitoring in Reducing Hospital Stays and In-Office Visits for Cardiac Patients Treated with Implantable Devices “The results from ...